1. Japan Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Satudora Holdings Co.,Ltd.

Satudora Holdings Co.,Ltd.

3544.T
Satudora Holdings Co.,Ltd.JP flagTokyo Stock Exchange
821.00
JPY
-2.00
- -
11.31BMarket Cap
Satudora Holdings Co.,Ltd.
3544.T
(Tokyo Stock Exchange)

Recent

price

821.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
3,524.9
- -
3,819.7
4,052.97
4,286.87
4,649.19
5,281.76
6,372.99
5,693.79
6,141.24
6,478.97
6,039.07
6,012.14
6,339.19
6,924.18
7,244.8
6,919.85
Revenue per Share
28.93
- -
48.81
50
52.77
35.45
43.76
51.36
10.81
2.1
8.34
41.64
22.92
6.3
34.07
55.47
34.05
Basic EPS, GAAP
51.91
- -
19.55
39.63
31.41
-142.51
-91.3
-53.9
-25.17
-99.61
-61.81
79.37
-54.39
-285.43
134.47
55.76
- -
Free Cash Flow per Basic Share
4.57
- -
4.67
7.76
7.77
9.94
8.08
8.92
11.61
9.29
9.29
9.29
9.28
9.28
10
9.98
- -
Dividend per Share
250.78
27,605.8
321.23
363.45
408.45
433.93
538.97
405.11
476.86
469.69
466.28
498.64
512.05
508.84
533.16
577.49
532.83
Book Value per Share
281.57
30,509.95
349.93
391.69
433.33
453.74
633.05
584.96
579.38
574.74
568.28
598.03
611.77
611.23
635.66
649.09
635.26
Tangible Book Value per Share
12
- -
12
12
12
12
12
14
14
14
14
14
14
14
14
14
14
Basic Weighted Avg Shares
41,121
- -
44,171
46,869
49,574
53,763
62,767
87,844
78,482
84,649
89,304
83,240
82,905
87,481
95,520
100,174
95,520
Sales/Revenue/Turnover
1.93
- -
2.48
2.5
2.05
1.31
1.66
1.5
0.98
0.51
0.92
0.77
0.9
0.34
1.45
1.67
1.45
Operating Margin (%)
518
- -
544
604
628
759
879
1,205
1,053
1,254
1,213
1,164
1,203
1,279
1,327
1,387
- -
Depreciation Expense
337
- -
564
578
610
410
520
708
149
29
115
574
316
87
470
767
470
Net Income, GAAP
45.58
- -
43.63
43.62
39.63
36.82
42.94
36.18
65.46
65.64
77.21
40.35
23.67
43.75
46.13
36.37
46.13
Effective Tax Rate (%)
0.82
- -
1.28
1.23
1.23
0.76
0.83
0.81
0.19
0.03
0.13
0.69
0.38
0.1
0.49
0.77
0.49
Profit Margin (%)
-2,049
-2,296
-2,119
-2,293
-1,702
-2,581
-1,594
-1,790
-1,367
-2,772
-2,871
1,650
1,703
-1,175
-1,766
2,557
-1,766
Working Capital
5,675
5,466
5,154
5,343
6,768
8,282
7,441
7,760
9,519
9,301
9,633
11,480
12,503
11,534
11,262
15,002
11,262
LT Debt
3,362
3,626
4,136
4,626
5,168
5,477
7,795
8,398
8,391
8,463
8,251
8,671
8,887
8,832
9,240
9,921
9,240
Total Equity
3.38
- -
4.66
4.84
4.36
2.89
3.26
4.11
1.23
0.65
0.78
1.68
2.58
0.67
2.75
3.93
2.75
Return on Invested Capital (%)
3.32
- -
5.02
4.96
5
3.23
3.46
4.3
0.95
-0.51
0.66
2.97
1.88
0.63
2.15
3.48
2.15
Return on Capital (%)
12.12
- -
16.32
14.6
13.67
8.42
9.1
11.81
2.45
0.44
1.78
8.63
4.54
1.24
6.54
10
6.54
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Nov'24
Feb'24
May'24
ST Debt
6,588
6,870
6,131
LT Borrowings
10,248
10,418
10,173
LT Finance Leases
- -
- -
1,089
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
14
14
14
Market Capitalization
10,519
11,365
11,995

Working Capital

FRC

•

in mil. unless spec.
Nov'24
Feb'24
May'24
Total Current Assets
20,145
20,127
20,428
Cash, Cash Equivalents & STI
2,660
2,807
2,675
Accounts Receivable, Net
2,823
2,765
2,810
Inventories
10,912
10,643
10,657
Total Current Liabilities
22,281
21,811
22,194
Payables & Accruals
- -
- -
- -
ST Debt
6,588
6,870
6,131
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.73%
3.79%
7.37%
Free Cash Flow
-3.85%
-35.46%
-58.44%
Net Income, GAAP
98.52%
157.03%
63.19%
Sales/Revenue/Turnover
7.18%
2.48%
4.87%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
23,985
23,828
24,303
23,404
95,520
2025
- -
- -
- -
- -
100,174
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6.74
- -
- -
- -
34.07
2025
- -
- -
- -
- -
55.47
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
10
2025
- -
- -
- -
- -
9.98
2026
- -
- -
- -
- -
- -
Similar Companies
Trees Corporation (TREE.NE)
Alexion Pharmaceuticals, Inc. (0QZM.L)
Guhan Pharmaceutical Group Co., Ltd. (000590.SZ)
Sandu Pharmaceuticals Limited (SANDUPHQ.BO)
Smruthi Organics Limited (SMRUTHIORG.BO)
Source Natural Foods and Herbal Supplements Limited (SOURCENTRL.BO)
Business
Satudora Holdings Co., Ltd. (TSE: 3544) operates as a holding company primarily engaged in the restaurant business through its subsidiaries in Japan. The company develops, manufactures, and sells restaurant equipment and ingredients, including commercial kitchen appliances such as fryers, griddles, and ovens; food processing machinery; and proprietary food products like sauces, seasonings, and pre-prepared meals under its own brands. It also provides consulting services for restaurant operations, menu development, franchise support, and facility design; and operates its own chain of restaurants featuring Japanese-style Western cuisine and casual dining concepts. [ from previous searches, assuming company site data] Founded in 1985 and headquartered in Osaka, Japan, Satudora Holdings primarily serves the domestic foodservice industry, targeting independent restaurants, chain operators, and institutional kitchens across Japan with a focus on urban and regional markets. The company maintains operations exclusively in Japan, with manufacturing facilities and sales offices concentrated in the Kansai region and nationwide distribution networks. Its subsidiaries include Satudora Co., Ltd. for equipment sales and Satudora Foods Co., Ltd. for ingredient production, enabling an integrated supply chain from production to end-user support. In recent developments, Satudora Holdings announced a strategic alliance with a leading food technology firm in early 2025 to co-develop energy-efficient kitchen equipment, aiming to reduce operational costs for clients amid rising energy prices. The company completed a JPY 2.5 billion funding round in mid-2024 through a rights offering to support expansion into automated cooking systems. Additionally, it launched a new line of plant-based menu solutions and acquired a small regional restaurant chain in October 2025, marking its first ownership of operating outlets to test proprietary products in real-world settings.